All Stories

  1. A Step toward Understanding the Story Behind the Pictures: Molecular Diagnostics and the Banff Classification of Renal Allograft Pathology
  2. Immunosuppressant Medication Use in Patients with Kidney Allograft Failure: A Prospective Multicenter Canadian Cohort Study
  3. Use and Outcomes of Induction Therapy in Well-Matched Kidney Transplant Recipients
  4. Understanding Risks and Our Responsibility to Living Donors
  5. Primacy in Kidney Allocation: Does It Alleviate the Barriers to Transplantation?
  6. Passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act—a Chance to Celebrate and Reflect
  7. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival
  8. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era
  9. Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy
  10. Referral for Kidney Transplantation in Canadian Provinces
  11. Access to Kidney Transplantation after a Failed First Kidney Transplant and Associations with Patient and Allograft Survival
  12. Screening Transplant Waitlist Candidates for Coronary Artery Disease
  13. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients
  14. Compelling Evidence of the Need for Policy Change to Decrease Deceased Donor Kidney Discard in the United States
  15. Association of Kidney Transplantation with Survival in Patients with Long Dialysis Exposure
  16. Use and Outcomes of Kidneys from Donation after Circulatory Death Donors in the United States
  17. The outstanding questions in transplantation: It's about time…
  18. Reciprocity to Increase Participation of Compatible Living Donor and Recipient Pairs in Kidney Paired Donation
  19. IntegratingAPOL1Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference
  20. Costimulation Blockade Holds Emerging Hope for Patients in Large Markets Only
  21. Financial Incompatibility and Paired Kidney Exchange: Walking a Tightrope or Blazing a Trail?
  22. Providing Coverage for the Unique Lifelong Health Care Needs of Living Kidney Donors Within the Framework of Financial Neutrality
  23. Towards Improving the Transfer of Care of Kidney Transplant Recipients
  24. Kidney Transplant iBook, edited by Leonardo V. Riella. 2015. 274 pages, http://www.leoriella.com/book
  25. Timing of Pregnancy After Kidney Transplantation and Risk of Allograft Failure
  26. US Transplant Policy Should Strengthen Bridges, Not Build Walls
  27. Waiting for a Deceased Kidney Donor Transplant: Better a Small Fish Than an Empty Dish?
  28. Transplantation Ethics. Second edition. Robert M.Veatch and Lainie F.Ross. Washington, DC: Georgetown University Press, 2015. 434 pp.
  29. Engaging Living Kidney Donors in a New Paradigm of Postdonation Care
  30. Focus Group Study of Public Opinion About Paying Living Kidney Donors in Australia
  31. Advances in the Understanding of Complement Mediated Glomerular Disease: Implications for Recurrence in the Transplant Setting
  32. Differential Association of Body Mass Index with Access to Kidney Transplantation in Men and Women
  33. Reply (Invited Response to 2 Letters re Iran Editorial)
  34. The Cost-Effectiveness of Using Payment to Increase Living Donor Kidneys for Transplantation
  35. Attitudes Toward Strategies to Increase Organ Donation: Views of the General Public and Health Professionals
  36. Living Donor Age and Kidney Allograft Half-Life: Implications for Living Donor Paired Exchange Programs